Corrigendum to a new oral testosterone undecanoate (TU) therapy comes of age for the treatment of hypogonadal men

Corrigendum to a new oral testosterone undecanoate (TU) therapy comes of age for the treatment of hypogonadal men

Bibliographic Details
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-08-01
Series:	Therapeutic Advances in Urology
Online Access:	https://doi.org/10.1177/17562872211036391

Similar Items

A new oral testosterone undecanoate therapy comes of age for the treatment of hypogonadal men
by: Ronald S. Swerdloff, et al.
Published: (2020-06-01)

Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men
by: Nandini Shankara Narayana, et al.
Published: (2021-07-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Published: (2013-03-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Published: (2012-12-01)

UGT2B17 genotype and the pharmacokinetic serum profile of Testosterone during substitution therapy with Testosterone Undecanoate. A retrospective experience from 207 men with hypogonadism.
by: Anne Kirstine eBang, et al.
Published: (2013-07-01)

Effects of Five-Year Treatment with Testosterone Undecanoate on Metabolic and Hormonal Parameters in Ageing Men with Metabolic Syndrome
by: Davide Francomano, et al.
Published: (2014-01-01)

Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy
by: Veerle Ide, et al.
Published: (2021-12-01)

Testosterone undecanoate effects on cardiovascular risk factors in men with metabolic syndrome
by: A. L. Vertkin, et al.
Published: (2008-10-01)

Hypogonadism and Testosterone Therapy
by: Avinash Maganty MD, et al.
Published: (2015-07-01)

Pharmacokinetics and Acceptability of Subcutaneous Injection of Testosterone Undecanoate
by: Conway, A, et al.
Published: (2019)

Pharmacokinetics and Acceptability of Subcutaneous Injection of Testosterone Undecanoate
by: Conway, A., et al.
Published: (2019)

Effect of a Combination of Omega-3 and Oral Testosterone Undecanoate On Serum Testosterone Levels in Patients with Testosterone Deficiency
by: Min Gu Park, et al.
Published: (2020-06-01)

Predicting Intestinal and Hepatic First-Pass Metabolism of Orally Administered Testosterone Undecanoate
by: Atheer Zgair, et al.
Published: (2020-10-01)

Testosterone Replacement Therapy and Bone Mineral Density in Men with Hypogonadism
by: Se Hwa Kim
Published: (2014-03-01)

Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study
by: Yin-Wei Chen, et al.
Published: (2019-01-01)

Strawberry Decreases Intraluminal and Intestinal Wall Hydrolysis of Testosterone Undecanoate
by: Atheer Zgair, et al.
Published: (2021-01-01)

Racial differences in hypogonadal improvement and prostate-specific antigen levels in hypogonadal men treated with testosterone replacement therapy
by: Robert M. Coward, et al.
Published: (2010-12-01)

Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy
by: Daniel A Shoskes, et al.
Published: (2015-12-01)

Evaluating the cardiovascular risk of testosterone replacement therapy in men with late-onset hypogonadism
by: Siyahian, Shant Armen
Published: (2016)

Testosterone therapy and bone quality in men with diabetes and hypogonadism: Study design and protocol
by: Vittoria Russo, et al.
Published: (2021-03-01)

Anaphylaxis Triggered by Benzyl Benzoate in a Preparation of Depot Testosterone Undecanoate
by: Gregory S. Y. Ong, et al.
Published: (2012-01-01)

Effect of Varicocele and Its Treatment on Testosterone in Hypogonadal Men with Varicocele: Review of the Literature
by: Selahittin Çayan, et al.
Published: (2020-05-01)

Research effects of Testosterone undecanoate administration on metabolic and hormonal parameters at men with an obesity and a chronic heart failure
by: N. P. Goncharov, et al.
Published: (2014-11-01)

Research effects of Testosterone undecanoate administration on metabolic and hormonal parameters at men with an obesity and a chronic heart failure
by: N. P. Goncharov, et al.
Published: (2014-11-01)

Cognitive effects of testosterone and finasteride administration in older hypogonadal men
by: Borst SE, et al.
Published: (2014-08-01)

Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men
by: Pranav Dadhich, et al.
Published: (2017-01-01)

The Effect of Testosterone Topical Solution in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel
by: Patrick R. Burns PharmD, et al.
Published: (2018-05-01)

Hypogonadism in the Aging Male Diagnosis, Potential Benefits, and Risks of Testosterone Replacement Therapy
by: Prasanth N. Surampudi, et al.
Published: (2012-01-01)

An update on the role of testosterone replacement therapy in the management of hypogonadism
by: Geoffrey Hackett
Published: (2016-04-01)

Effect of a Combination of Dutasteride and Parenteral Testosterone Undecanoate on Testosterone Deficiency Symptoms and Prostate in Patients with Testosterone Efficiency and Benign Prostatic Hyperplasia
by: Min Gu Park, et al.
Published: (2020-06-01)

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
by: Kishore M Lakshman, et al.
Published: (2009-10-01)

The long-term effects of testosterone replacement therapy in aging males with late-onset hypogonadism
by: Clausen, Jonathan
Published: (2020)

Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum Testosterone
by: Yan-Jiao Wang, et al.
Published: (2013-01-01)

Benefits and Harms of Testosterone Replacement Therapy in Hypogonadal Men: A Systematic Review and Network Meta-analysis
by: Elliott, Jesse
Published: (2016)

Possibilities оf use of testosterone undecanoate in treatment in stroke male patients with type 2 diabetes mellitus
by: L. Yu. Morgunov, et al.
Published: (2014-11-01)

Possibilities оf use of testosterone undecanoate in treatment in stroke male patients with type 2 diabetes mellitus
by: L. Yu. Morgunov, et al.
Published: (2014-11-01)

Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events
by: Zelal Jaber Kharaba, et al.
Published: (2020-09-01)

The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
by: Yu Seob Shin, et al.
Published: (2019-02-01)

Late-onset hypogonadism: beyond testosterone
by: Carlo Foresta, et al.
Published: (2015-04-01)

Occurrence of Pulmonary Oil Microembolism After Testosterone Undecanoate Injection: A Postmarketing Safety Analysis
by: Alexander W. Pastuszak, MD, PhD, et al.
Published: (2020-06-01)